Search research articles
Contact Us
Filters
Showing results (311-320 of 362) with videos related to
Page
of 37
Sort By:
The Journal of Biological Chemistry
|
August 28, 2001
A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box
T Hanada, T Yoshida, I Kinjyo, et al.
Kidney International. Supplement
|
July 21, 1999
Effect of simvastatin on proliferative nephritis and cell-cycle protein expression
A Yoshimura, T Nemoto, Y Sugenoya, et al.
British Journal of Cancer
|
May 5, 2005
Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)
Y Kokubo, A Gemma, R Noro, et al.
Oncogene
|
February 16, 1999
APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis
M Yokouchi, T Wakioka, H Sakamoto, et al.
The Journal of Biological Chemistry
|
August 29, 1998
Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5
Y Okajima, I Matsumura, T Nishiura, et al.
Cell Transplantation
|
September 1, 1996
Effect of complement activation in human serum on isolated porcine islets
T Kin, Y Nakajima, H Kanehiro, et al.
Kidney International
|
September 1, 1991
Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization
A Yoshimura, K Gordon, C E Alpers, et al.
Journal of Periodontal Research
|
November 22, 2017
Crystalline structure of pulverized dental calculus induces cell death in oral epithelial cells
S M Ziauddin, A Yoshimura, J L Montenegro Raudales, et al.
The EMBO Journal
|
March 4, 1999
The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
H Yasukawa, H Misawa, H Sakamoto, et al.
British Journal of Cancer
|
February 16, 2012
Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules
T Shimokawa, M Seike, C Soeno, et al.
Page
of 37
Search research articles
Search
Showing results (311-320 of 362) with videos related to
Sort By:
Page
of 37
The Journal of Biological Chemistry
|
August 28, 2001
A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box
T Hanada, T Yoshida, I Kinjyo, et al.
Kidney International. Supplement
|
July 21, 1999
Effect of simvastatin on proliferative nephritis and cell-cycle protein expression
A Yoshimura, T Nemoto, Y Sugenoya, et al.
British Journal of Cancer
|
May 5, 2005
Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)
Y Kokubo, A Gemma, R Noro, et al.
Oncogene
|
February 16, 1999
APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis
M Yokouchi, T Wakioka, H Sakamoto, et al.
The Journal of Biological Chemistry
|
August 29, 1998
Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5
Y Okajima, I Matsumura, T Nishiura, et al.
Cell Transplantation
|
September 1, 1996
Effect of complement activation in human serum on isolated porcine islets
T Kin, Y Nakajima, H Kanehiro, et al.
Kidney International
|
September 1, 1991
Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization
A Yoshimura, K Gordon, C E Alpers, et al.
Journal of Periodontal Research
|
November 22, 2017
Crystalline structure of pulverized dental calculus induces cell death in oral epithelial cells
S M Ziauddin, A Yoshimura, J L Montenegro Raudales, et al.
The EMBO Journal
|
March 4, 1999
The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
H Yasukawa, H Misawa, H Sakamoto, et al.
British Journal of Cancer
|
February 16, 2012
Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules
T Shimokawa, M Seike, C Soeno, et al.
Page
of 37